Henlius partners Getz Pharma to commercialize adalimumab biosimilar in new markets by Editor | Mar 7, 2022 | Hospitals, LATEST NEWS, WORLD NEWS | 0 CHINA –Henlius and Getz Pharma have partnered to commercialize Henlius’ adalimumab biosimilar in... Read More